Cargando…
Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir
Outcomes of various clinical studies for the coronavirus disease 2019 (COVID-19) treatment indicated that the drug acts via inhibition of multiple pathways (targets) is likely to be more successful and promising. Keeping this hypothesis intact, the present study describes for the first-time, Grazopr...
Autores principales: | Behera, Santosh Kumar, Vhora, Nazmina, Contractor, Darshan, Shard, Amit, Kumar, Dinesh, Kalia, Kiran, Jain, Alok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012565/ https://www.ncbi.nlm.nih.gov/pubmed/33790352 http://dx.doi.org/10.1038/s41598-021-86712-2 |
Ejemplares similares
-
Recent Advances in In-Vitro Assays for Type 2 Diabetes Mellitus: An Overview
por: Vhora, Nazmina, et al.
Publicado: (2021) -
Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
por: Abidi, Syed Hani, et al.
Publicado: (2021) -
Elbasvir/grazoprevir treatment in an HCV-infected peritoneal dialysis patient
por: Chen, Jin, et al.
Publicado: (2020) -
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial
por: Zhdanov, Konstantin, et al.
Publicado: (2020) -
Structural basis of Omicron immune evasion: A comparative computational study
por: Contractor, Darshan, et al.
Publicado: (2022)